mobile-bannertablet-bannerdesktop-banner
fda-recall-birth-control-mibelas-fe
Lupin Pharmaceuticals Inc. announced a nationwide recall of Mibelas™ 24 Fe tablets due to sequencing errors and missing expiration dates FDA

Birth Control Pills Recalled Because Packaging Error Could Lead to Unintended Pregnancy

Jun 09, 2017
TIME Health
For more, visit TIME Health.

A pharmaceutical company has recalled widely-distributed birth control pills for a packaging error that the Food and Drug Administration (FDA) warns, if taken, could lead to an unintended pregnancy.

Lupin Pharmaceuticals announced a recall of the chewable pills, sold under the name Mibelas 24 F-E, on May 29. The pills were packaged in a way that reversed the tablets' order, meaning that the first four pills were non-hormonal placebos rather than the active tablets they were supposed to be.

"As a result of this packaging error, oral contraceptive tablets that are taken out of sequence may place the user at risk for contraceptive failure and unintended pregnancy," the FDA's statement reads.

The FDA warns that the packaging error also means taking the pills could cause "significant" harm to both maternal and fetal health. However, at the time of writing, no such adverse events have been reported.

The pills, which are packaged in blister packs containing 28 tablets, were distributed nationwide in the U.S. to wholesalers, clinics and retail pharmacies. Consumers who have the product are advised to return the product to the pharmacy or place of purchase, as well as contact their healthcare provider if they have experienced any adverse effects.

Consumers who have questions about the recall can call the manufacturer, Lupin Pharmaceuticals, at 800-399-2561.

All products and services featured are based solely on editorial selection. TIME may receive compensation for some links to products and services on this website.